CAI Q1 2018 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95M+17.0% YoY

Gross Profit

$48M50.2% margin

Operating Income

$33M34.1% margin

Net Income

$17M18.0% margin

EPS (Diluted)

$0.83

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

-$74M

Stock-Based Comp.

$604,000

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.9B

Stockholders' Equity

$623M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95M	$82M	+17.0%
Gross Profit	$48M	$36M	+31.3%
Operating Income	$33M	$19M	+72.8%
Net Income	$17M	$5M	+225.1%